Last reviewed · How we verify
NCT06174142
Comparing Two Protocols of Shock Wave Therapy for Patients With Plantar Fasciitis
NA trial testing High-Frequency ESWT in Plantar Fasciitis in 64 participants. Status unknown.
5 January 2024
Quick facts
| Lead sponsor | University of Sharjah |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 20 December 2023 |
| Primary completion | 5 January 2024 |
| Estimated completion | 25 January 2024 |
Drugs / interventions tested
- High-Frequency ESWT
- Low-Frequency ESWT Group
- Sham ESWT Control Group
Conditions studied
- Plantar Fasciitis — all drugs for Plantar Fasciitis →
Sponsor
University of Sharjah
Who can join
Adults 20 to 50, any sex, with Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the efficacy of two distinct shock wave therapy protocols and their impact on improving function and reducing pain in individuals with plantar fasciitis, a common cause of heel pain that affects millions worldwide. The key questions the study aims to address are: How effective is each shock wave therapy protocol in enhancing functional ability without pain in patients with plantar fasciitis? Does either protocol offer a significant benefit over the other in terms of pain relief and functional improvement after a course of six treatment sessions? Participants will be randomly assigned to one of three groups and will engage in the study as follows: Undergo six sessions of shock wave therapy with parameters specific to their assigned group. Complete questionnaires assessing foot function and pain levels. Participate in evaluations before, during, and after the treatment to monitor their progress. The three groups in the comparison are as follows: Group A will receive shock wave therapy at a higher frequency and specific intensity, with a set number of impulses. Group B will undergo therapy with a different frequency and intensity level but will receive the same number of impulses. Group C, the control group, will receive a sham therapy, mirroring the treatment experience without the therapeutic effects to serve as a baseline for comparison. The study is anticipated to delineate a more effective protocol for treating plantar fasciitis with shock wave therapy. The findings may contribute to enhanced treatment guidelines, potentially resulting in faster recovery times for patients. The participation of individuals in this research will offer valuable insights that could inform future therapeutic strategies for managing plantar fasciitis
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparing two protocols of shock wave therapy for patients with plantar fasciitis: A pilot study.
A L Kalbani F, Shalash R, Qadah R, Shousha T. · · 2024 · cited 1× · PMID 38709797 · DOI 10.1371/journal.pone.0302553
Verify or expand the search:
- PubMed search for NCT06174142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plantar Fasciitis
Currently open trials in the same condition.
- NCT07294196 — Percutaneous Electrolysis Targeting the Muscle-Fascia Chain for Treating Chronic Plantar Fasciitis in Adults · NA · recruiting
- NCT07463794 — Comparison of Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy in Plantar Fasciitis · NA · active not recruiting
- NCT07383558 — Effect of Additional Sural Nerve PRF in Chronic Heel Pain · recruiting
- NCT07242729 — Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis · NA · recruiting
- NCT06967168 — HeEL Pain Pathways Feasibility Study · NA · recruiting
Other University of Sharjah trials
Trials by the same sponsor.
- NCT07436507 — Effects of a Combined Home-Based Exercise Program on Dual-Task Gait Performance, EEG Markers of Cognitive-Motor Control, · NA · not yet recruiting
- NCT07434934 — Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis · NA · not yet recruiting
- NCT07009561 — Cortical Excitability and Typing Performance After Action Observation and Motor Execution · NA · not yet recruiting
- NCT06756256 — Effect of Foot Insole on Body Alignment, and in Stroke Patients · NA · completed
- NCT06762912 — The Short-term Effect of Low-load Resistance Training with Blood-flow Restriction on Somatosensory-evoked Potentials in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06174142 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sharjah
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06174142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing